Table 4.
Comparison of Clinical Characteristics and Laboratory Data Between Subjects With and Without Response to Shockwave Therapy.
| Parameter | Subjects without response (N = 17) |
Subjects with response (N = 35) |
p value |
|---|---|---|---|
| Age (years) | 61.4 ± 10.5 | 59.4 ± 12.1 | .57 |
| Body mass index (kg/m2) | 25.8 ± 2.9 | 25.1 ± 2.0 | .29 |
| Duration of erectile dysfunction (month) | 39.6 ± 24.1 | 37.6 ± 27.1 | .80 |
| Severity of erectile dysfunction, n (%) | |||
| Initial EHS1 | 9 (64.3) | 5 (35.7) | .005 |
| Initial EHS2 | 8 (21.1) | 30 (78.9) | |
| IIEF-5 | 8.1 ± 2.8 | 10.4 ± 2.7 | .01 |
| Diabetes mellitus, n (%) | 7 (50.0) | 7 (50.0) | .11 |
| Diabetes mellitus with insulin control, n (%) | 3 (60.0) | 2 (40.0) | .37 |
| Hypertension, n (%) | 8 (29.6) | 19 (70.4) | .63 |
| Dyslipidemia, n (%) | 11 (35.5) | 20 (64.5) | .60 |
| Cardiovascular disease, n (%) | 2 (28.6) | 5 (71.4) | .80 |
| Stroke, n (%) | 0 (0) | 0 (0) | |
| Hypogonadism, n (%) | 4 (44.4) | 5 (55.6) | .41 |
| Current smoking, n (%) | 3 (27.3) | 8 (72.7) | .19 |
| Current alcohol drinking, n (%) | 1 (11.1) | 8 (88.9) | .13 |
| Number of comorbidities | 2.0 ± 1.3 | 1.7 ± 1.2 | .29 |
| Laboratory data | |||
| Total testosterone (ng/dL) | 492.9 ± 198.3 | 505.6 ± 178.9 | .82 |
| Triglycerides (mg/dL) | 104.9 ± 56.4 | 115.9 ± 58.5 | .52 |
| Total cholesterol (mg/dL) | 189.0 ± 35.4 | 192.2 ± 33.6 | .76 |
| High-density lipoprotein (mg/dL) | 47.4 ± 17.4 | 46.6 ± 11.5 | .86 |
| Fasting blood sugar (mg/dL) | 132.4 ± 54.7 | 104.8 ± 16.9 | .058 |
Note. EHS = erection hardness score; IIEF-5 = 5-item version of the International Index of Erectile Function.